TY - JOUR
T1 - Blood culture practices and microbiological capacity for sepsis diagnostics in Europe (2021–2022)
T2 - a cross-sectional analysis of the European Sepsis Care Survey
AU - Scheer, Christian S.
AU - Giamarellos-Bourboulis, Evangelos J.
AU - Annane, Djillali
AU - Artigas, Antonio
AU - Tarik Aslan, Abdullah
AU - Bottari, Gabriella
AU - Bouma, Hjalmar R.
AU - Černý, Vladimir
AU - Curić Radivojević, Renata
AU - Dewitte, Ken
AU - Filipescu, Daniela
AU - Gründling, Matthias
AU - Hästbacka, Johanna
AU - Laribi, Said
AU - Lassen, Annmarie
AU - Lebedinskii, Konstantin
AU - Linder, Adam
AU - Máca, Jan
AU - Malbrain, Manu L.N.G.
AU - Monti, Gianpaola
AU - Ostermann, Marlies
AU - Osthoff, Michael
AU - Paiva, José Artur
AU - Sabbatucci, Michela
AU - Śmiechowicz, Jakub
AU - Ştefan, Mihai Gabriel
AU - Vollmer, Marcus
AU - Vuković, Natalija
AU - Zaragkoulias, Kyriakos
AU - Reinhart, Konrad
AU - Ferrer, Ricard
AU - Idelevich, Evgeny A.
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/12
Y1 - 2025/12
N2 - Background: Blood cultures (BCs) are key diagnostic elements for sepsis patients. Accurate preanalytical procedures are substantial, and results should be available as soon as possible to guide adequate antimicrobial treatment. This study aimed to evaluate BC collection practices and diagnostic capacity across European hospitals. Methods: This cross-sectional survey investigated BC diagnostics in acute care hospitals across 37 European countries in the years 2021 and 2022. Analyses included BC guidelines, collection sites, number of BC sets in emergency departments (EDs), wards, and intensive care units (ICUs). We also examined transfer after collection, the use of on-site vs. external laboratories, opening hours, rapid testing capacity, and turn-around times of BCs processed in microbiology laboratories with different infrastructures. Findings: Responses were collected from 907 hospitals in Europe. BC guidelines were available in 84·4% (741/878) of the hospitals. BCs were preferably collected by multiple-site sampling in EDs (62·7%, 461/735), in wards (64·0%, 513/802) and ICUs (68·5%, 518/756). One BC set was preferred in EDs in 38·4% (270/704), in wards in 40·5% (314/775), and ICUs in 34·9% (261/748). Two BC sets were preferred in EDs in 31·0% (218/704), in wards in 28·1% (218/775), and ICUs in 39·2% (293/748). 48·0% (402/838) of hospitals used on-site and 52·0% (436/838) external microbiology laboratories. Around-the-clock microbiological services were available in 10⋅0% (91/907), and rapid pathogen identification in 43·7% (396/907) of hospitals. Infrastructure with around-the-clock microbiological service and rapid testing was available in 7·4% (62/840) of hospitals, and probability of a final microbiological result within two days was highest in these hospitals compared to hospitals with limited microbiology service (for BC collected on wards: 19·6% vs. 52·7%, Odds Ratio 4·59 [95% CI 2·50–7·79], p < 0·0001). Interpretation: Despite the availability of BC guidelines in many hospitals, current recommendations for BC collection were often neglected. Rapid testing capacity was limited in most microbiological laboratories, and around-the-clock service for BCs was very rare. As delay in results may have a detrimental impact on patient outcomes, strategies to improve these processes are urgently needed. Funding: The European Sepsis Alliance and a grant by Becton and Dickinson.
AB - Background: Blood cultures (BCs) are key diagnostic elements for sepsis patients. Accurate preanalytical procedures are substantial, and results should be available as soon as possible to guide adequate antimicrobial treatment. This study aimed to evaluate BC collection practices and diagnostic capacity across European hospitals. Methods: This cross-sectional survey investigated BC diagnostics in acute care hospitals across 37 European countries in the years 2021 and 2022. Analyses included BC guidelines, collection sites, number of BC sets in emergency departments (EDs), wards, and intensive care units (ICUs). We also examined transfer after collection, the use of on-site vs. external laboratories, opening hours, rapid testing capacity, and turn-around times of BCs processed in microbiology laboratories with different infrastructures. Findings: Responses were collected from 907 hospitals in Europe. BC guidelines were available in 84·4% (741/878) of the hospitals. BCs were preferably collected by multiple-site sampling in EDs (62·7%, 461/735), in wards (64·0%, 513/802) and ICUs (68·5%, 518/756). One BC set was preferred in EDs in 38·4% (270/704), in wards in 40·5% (314/775), and ICUs in 34·9% (261/748). Two BC sets were preferred in EDs in 31·0% (218/704), in wards in 28·1% (218/775), and ICUs in 39·2% (293/748). 48·0% (402/838) of hospitals used on-site and 52·0% (436/838) external microbiology laboratories. Around-the-clock microbiological services were available in 10⋅0% (91/907), and rapid pathogen identification in 43·7% (396/907) of hospitals. Infrastructure with around-the-clock microbiological service and rapid testing was available in 7·4% (62/840) of hospitals, and probability of a final microbiological result within two days was highest in these hospitals compared to hospitals with limited microbiology service (for BC collected on wards: 19·6% vs. 52·7%, Odds Ratio 4·59 [95% CI 2·50–7·79], p < 0·0001). Interpretation: Despite the availability of BC guidelines in many hospitals, current recommendations for BC collection were often neglected. Rapid testing capacity was limited in most microbiological laboratories, and around-the-clock service for BCs was very rare. As delay in results may have a detrimental impact on patient outcomes, strategies to improve these processes are urgently needed. Funding: The European Sepsis Alliance and a grant by Becton and Dickinson.
KW - Blood culture analysis
KW - Blood cultures
KW - Clinical practice
KW - Diagnostics
KW - Infrastructure
KW - Multiple-site sampling
KW - Number of blood cultures sets
KW - Opening hours
KW - Pre-analytical practice
KW - Rapid testing
KW - Sepsis
KW - Single-site sampling
KW - Turn-around time
UR - https://www.scopus.com/pages/publications/105027568755
U2 - 10.1016/j.lanepe.2025.101570
DO - 10.1016/j.lanepe.2025.101570
M3 - Article
AN - SCOPUS:105027568755
SN - 2666-7762
VL - 62
JO - The Lancet Regional Health - Europe
JF - The Lancet Regional Health - Europe
M1 - 101570
ER -